Pharmacokinetics of sufentanil in the elderly surgical patient
- 1 November 1990
- journal article
- research article
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 37 (8) , 852-856
- https://doi.org/10.1007/bf03006620
Abstract
The effect of age on the distribution and elimination of sufentanil was studied in seven elderly (77 ± 5 yr, mean ± SD) and seven younger (41 ± 15 yr) neurosurgical patients. Following a single IV bolus of sufentanil 2 μg · kg−1 multiple arterial samples were obtained at timed intervals and plasma concentrations of sufentanil were measured by radioimmunoassay. Pharmacokinetic variables were calculated from the derived compartmental models. The initial volume of distribution was significantly smaller in the elderly patients (310 ± 109ml · kg−1 vs 491 ± 112 ml · kg−1 mean ± SD). Elimination halflives, plasma clearances, and total volumes of distribution were similar for elderly and younger subjects. Six of seven elderly patients required administration of naloxone at the termination of surgery to achieve an adequate rale of ventilation (> eight breaths · min−1) while only one younger patient required antagonism of ventilatory depression. The authors believe that agerelated differences in the action of sufentanil cannot be accounted for by the observed differences in the initial volume of distribution. It is concluded that alterations in pharmacodyamics appear to be of greater importance in the prolonged opioid effect seen in the elderly. L’effet de l’âge sur la distribution et l’élimination du sufentanil a été étudié chez sept patients âgés (77 ± 5 ans, moyenne ± SD) et sept patients moins âgés (41 ± 15 ans) devant subir des procedures neurochirurgicales. Après un bolus intraveineux unique de sufentanil de 2 μg · kg−1, des échantillons artériels multiples out été obtenus à des intervalles règuliers et des concentrations plasmatiques de sufentanil out été mesurées par radio-immuno-essai. Les variables pharmacocinétiques out été calculées. Le volume initial de distribution était significativement plus petit chez les patients plus ages (310 ± 109 ml · kg−1 moyenne ± SD). Les demivies d’élimination, les clairances plasmatiques, les volumes totaiix de distribution étaient similaires pour les patients ages et les sujets pl us jeunes. Six des sept patients ages out requis l’administration de naloxone à la fin de la chirurgie afin d’acquérir une fréquence de ventilation adequate (> 8 respirations · min−1) alors qu’un sent patient plus jeune a requis un antagonisme de sa depression respiratoire. Les auteurs croienl que les differences reliees à l’âge dans l’effet du sufentanil ne peuvent être attribuées aux differences du volume de distribution initial. On conclut que les altérations de la pharmacodynamique apparaissent plus importante dans la prolongation des effets des opiacés observes chez les gens ages.This publication has 26 references indexed in Scilit:
- The Pharmacokinetics of Sufentanil in Surgical PatientsAnesthesiology, 1984
- The Effect of Age on Central and Regional HemodynamicsGerontology, 1984
- Ventilatory response to morphine in young and old subjectsAnaesthesia, 1983
- Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Preliminary pharmacokinetic profile in manJournal of Pharmacy and Pharmacology, 1983
- Drug Disposition in Old AgeNew England Journal of Medicine, 1982
- Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the dataJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Statistical estimations in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1974
- Adult lean body mass declines with age: Some longitudinal observationsMetabolism, 1970
- Serum Protein Patterns in ‘Normal’ and Pathological AgeingGerontology, 1964
- Changes in Cardiac Output with AgeCirculation, 1955